David S. Boyer, MD

Articles by David S. Boyer, MD

Q&A: Evolving approaches to geographic atrophy management

ByDavid S. Boyer, MD,Matt Hoffman

January 17th 2026

Optigo: Lead anti-VEGF program advancing toward IND-enabling studies

ByDavid S. Boyer, MD, Arshad M. Khanani, MD, MA, FASRS,Sheryl Stevenson

November 8th 2025

Ophthalmologists weigh in on how the extended-duration therapy may reduce treatment burden for patients with wet age-related macular degeneration.

Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy

ByDavid S. Boyer, MD,Sydney M Crago

June 5th 2025

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, offering reduced risks and improved outcomes.

David S. Boyer, MD

Articles by David S. Boyer, MD

Q&A: Evolving approaches to geographic atrophy management

Optigo: Lead anti-VEGF program advancing toward IND-enabling studies

Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy

Latest Updated Articles

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Metformin use associated with reduced incidence of intermediate AMD

Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss

NeuroOp Guru: Understanding optic disc cupping after optic neuritis

China's NMPA approves ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic surgical microscopes for clinical use

Last year in glaucoma at EnVision Summit 2025